Fouda 2015.

Trial name or title	Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion (IUD)
Methods	Location: Cairo, Egypt Recruitment time: January 2015 to July 2015 Sample size calculation and outcome of focus: no mention
Participants	General with N: 90 women, 18 to 50 years old Source: Obstetrics and Gynecology Department, Cairo University Inclusion criteria: reproductive age, requesting IUD for contraception Exclusion criteria: contraindication to IUD insertion (< 6 weeks postpartum, < 2 weeks after abortion, uterine anomalies, fibroid distorting uterine cavity, pregnancy, PID, cervicitis, uterine depth < 6 cm or > 9 cm) , previous IUD insertion, allergy to diclofenac or lidocaine, peptic ulcer, asthma, bleeding disorders, cardiac, liver or kidney diseases)
Interventions	1) Diclofenac (100 mg) 1 hour before IUD insertion; lidocaine gel placed on cervix 3 min before IUD insertion 2) Placebo tablet 1 hour before IUD insertion; placebo gel placed on cervix 3 min before IUD insertion
Outcomes	Primary: intensity of pain during procedure; assessed by VAS Secondary: adverse effects of diclofenac and lidocaine
Starting date	January 2015
Contact information	Usama M Fouda, MD, PhD; 01095401375 ext 2; umfrfouda@yahoo.com
Notes